DXCM241213C89000
- 0.17
- 0.000.00%
DexCom Newsroom
10 BofA U.S. Options Overwriting Ideas
Unusual Options Activity: ACI, FTI and Others Attract Market Bets, ACI V/OI Ratio Reaches 75.0
Market Climbs on CPI Inflation and Likelihood of Rate Cuts | Livestock
Citigroup Raises DexCom Price Target to $91 From $85, Maintains Buy Rating
Wells Fargo Maintains DexCom(DXCM.US) With Buy Rating, Raises Target Price to $94
Wells Fargo Remains a Buy on Dexcom (DXCM)
Express News | Dexcom, Inc. : Wells Fargo Raises Target Price to $94 From $90
BofA Securities Maintains DexCom(DXCM.US) With Buy Rating, Maintains Target Price $90
Market Falls Wednesday, but Googles Chip Impresses | WST
DexCom Put Volume Heavy and Directionally Bearish
Dexcom Shares up as Diabetes Association Updates Guidelines
Google's Quantum Chip Might Have Contacted Parallel Universes | Live Stock
BofA Securities Maintains DexCom(DXCM.US) With Buy Rating, Announces Target Price $90
Express News | Watching Shares Of DexCom; Traders Circulating Note American Diabetes Association Updates Standards To Recommend Continuous Glucose Monitoring For Non-Insulin Type 2 Diabetes Patients, Paving Way For Broader Coverage And Market Growth; Bank Of America...
Express News | Tandem T:Slim X2 Insulin Pump Now Compatible With Dexcom G7 Cgm in Canada
Tandem T:slim X2 Insulin Pump Now Compatible With Dexcom G7 CGM in Canada
Is DexCom Stock Underperforming the Nasdaq?
DexCom Is Maintained at Buy by Canaccord Genuity
DexCom Analyst Ratings
Monday Market Falls, Chinese Stocks Climb, Indices Rebalance | Live Stock